US$ 20.43
tirzepatide 0.5 Lilly launches lower-price weight-loss drug without injector pen Tirzepatide | DirectMeds
Description
Weight loss drugs can cost thousands per year without insurance

Discover their long-term benefits for heart, kidneys, liver, and brain health.

Professor Jens Juul Holst, co-discoverer of GLP-1, on the science behind Ozempic and Wegovy, the LEADER trial and the obesity revolution.

Each pen contains four measured subcutaneous doses of 7.5 mg
